Federal Register Notice: FDA has determined that 15 drug products were not withdrawn from sale for reasons of safety or effectiveness. This determination will allow the agency to continue to approve ANDAs that refer to the products as long as they meet relevant legal and regulatory requirements. To view this notice, click here.
